Resources

Welcome to our searchable resource and literature collection on safer supply and related topics.

Found a broken link? Links do move around, so if you find one here that's broken, please let us know through the Contact form.

 

The evolving drug epidemic of prescription opioid injection and its association with HCV transmission among people who inject drugs in Montréal, Canada

To examine temporal trends in prescription opioid (PO) injection and to assess its association with hepatitis C virus (HCV) seroconversion among people who inject drugs (PWID).
Original research | 2019
Evidence base, Safer supply, About prescribers

Virtual Overdose Response for People Who Use Opioids Alone: Protocol for a Feasibility and Clinical Trial Study

This clinical trial aims to test the feasibility of a service that provides virtual overdose response in order to help prevent deaths in populations that cannot or will not access physical supervised
Other | 2021
Overdose, Harm reduction, Illegal drugs

Xylazine detected in unregulated opioids and drug administration equipment in Toronto, Canada: clinical and social implications

In September 2020, xylazine was first detected by Toronto’s Drug Checking Service
Original research | 2021
Overdose, Mortality, Harm reduction, Policy/Regulatory, Decriminalization/legalization, Drug checking

Yet they failed to do so: recommendations based on the experiences of NAOMI research survivors and a call for action

Drawing on brainstorming sessions and focus groups that were conducted in the summer of 2011, this paper highlights the experiences of NPA members in their own words.
Original research | 2013
Policy/Regulatory, Wrap-around services, Safer supply, Decriminalization/legalization, Equity, Advocacy, About PWUD, Social services, Outcomes, Peer/PWLLE program involvement, Social benefits, Stigma

BCCSU Webinars

Archived webinar | various
Clinical guidance, Policy/Regulatory, Safer supply, About prescribers, Injecting drugs

BCCSU Webinars: COVID-19, Substance Use, and Safer Supply

Archived webinar | 2020
Clinical guidance, Harm reduction, Safer supply, About pharmacists, About prescribers, Housing

Cost-effectiveness of hydromorphone for severe opioid use disorder: findings from the SALOME randomized clinical trial

The current study aimed to compare the cost-effectiveness of hydromorphone directly with diacetylmorphine and indirectly with methadone maintenance treatment.
Original research | 2018
Evidence base, Safer supply, Crime, Substitution/OAT

Examining factors that shape use and access to diverted prescription opioids during an overdose crisis: A qualitative study in Vancouver, Canada

PO diversion is widely regarded as a driver of OD mortality.
Original research | 2021
Harm reduction, Safer supply, About PWUD, Barriers and enablers, Poverty, Diversion

Fentanyl Buccal Tablet In Breakthrough Pain in Opioid-Tolerant Patients with Cancer

Report | 2006
Clinical guidance, Chronic pain

Guidance for Injectable Opiod Agonist Treatment for Opioid Use Disorder

Guidelines | 2017
Clinical guidance, Evidence base, Policy/Regulatory, About prescribers

Guideline for the Clinical Management of Opioid Use Disorder

Guidelines | 2023
Clinical guidance, Policy/Regulatory, About prescribers

Implementing social interventions in primary care

We discuss accumulated evidence (Box 1) on social interventions and provide an overview of common primary care–based interventions (Table 1), highlighting their strengths, limitations and feasibility
Lit review | 2021
Clinical guidance, Wrap-around services, Equity, About prescribers, Social services

Injectable opioid agonist treatment for patients with opioid dependence: a review of clinical and cost-effectiveness

What is the clinical effectiveness of injectable opioid agonist treatment for patients with opioid dependence?
Lit review | 2020
Mortality, Evidence base, Outcomes, Social benefits

Outcome of long-term heroin-assisted treatment offered to chronic, treatment-resistant heroin addicts in the Netherlands

To describe 4-year treatment retention and treatment response among chronic, treatment-resistant heroin-dependent patients offered long-term heroin-assisted treatment (HAT) in the Netherlands.
Original research | 2009
Evidence base, Harm reduction, Safer supply, About prescribers, Outcomes, Illegal drugs

Peer Payment Standards for Short-Term Engagements

Created in collaboration with peers and providers
Guidelines | 2018
About prescribers, About PWUD, Workplace, Peer/PWLLE program involvement

Policy in focus: Is psilocybin the next cannabis?

Commentary | 2021
Policy/Regulatory, Decriminalization/legalization, About prescribers, Hallucinogens/psychedelics

Research summary: Diverted prescription opioids study

Handout | 2021
Safer supply, Illegal drugs, Diversion

Risk Mitigation in the Context of Dual Public Health Emergencies

BC safe suply interim guidance for safe supply/COVID-19 risk mitigation during the pandemic

Guidelines | 2022
Overdose, Clinical guidance, Harm reduction, Safer supply, About prescribers, Rural/remote, Substitution/OAT, Carries/take-home doses

Supervised Consumption Services: Operational Guidance

Guidelines | 2017
Clinical guidance, Policy/Regulatory, About prescribers, SCS/OPS

The cost-effectiveness of Vancouver's supervised injection facility

The cost-effectiveness of Canada's only supervised injection facility has not been rigorously evaluated.
Original research | 2008
Evidence base, Advocacy, Illegal drugs, Social benefits, SCS/OPS

Refine Your Search

Keywords
Format
Region